Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iTBS plus medication for adolescent major depressive disorder
ChiCTR2600120127Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: BDI-II score. Started Mar 2026; status: recruiting.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2600120127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120127.